Viewing Study NCT04837703

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 7:18 PM
Ignite Modification Date: 2026-04-29 @ 7:18 AM
Study NCT ID: NCT04837703
Status: AVAILABLE
Last Update Posted: 2025-12-05
First Post: 2021-04-07
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: MAP to Provide Access to Eltrombopag, for Treatment of Patients With Medically Significant Thrombocytopenia
Sponsor: Novartis Pharmaceuticals
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Thrombocytopenia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Eltrombopag View
None thrombocytopenia View
None Idiopathic thrombocytopenic purpura View
None ITP View
None Severe aplastic anemia View
None SAA View
None HCV View
None Hepatitis C virus View